Xi Feng

Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO

Xi Feng, Pei Shen, Yinuo Wang et al. · Biochemical Pharmacology · 2019 · 31 citations

Medicinal Chemistry, Vivo Antitumor Evaluation, Drug Targeting +6

Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents

Xi Feng, Lixia Pan, Zhiyu Qian et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer

Qianming Du, Xi Feng, Yinuo Wang et al. · European Journal of Medicinal Chemistry · 2019 · 30 citations · Full text

Oncology, Medicine, Phosphonamidate Ido1 Inhibitors +9

Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions

Zhen Qin, Lian Qin, Xi Feng et al. · Journal of Medicinal Chemistry · 2021 · 20 citations · Full text

Inhibition of Lung Carcinoma A549 Cell Growth by Knockdown of Hexokinase 2 In Situ and In Vivo

Xi Feng, Jianghao Ye · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2016 · 19 citations · Full text

Oncology, Oncogenic Agent, Medicine +15